CNQ · MDMA.CN
Pharmala Biotech Holdings Inc.
CA$0.16CA$0.00 (0.0%)
Pharmala Biotech Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.52% below the high.
Loading market information…
CNQ · UDOC.CN · CAD
Stock price, earnings
Quote as of Oct 29, 2026, 03:13 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Unidoc Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Unidoc Health Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Vancouver, Canada, UniDoc Health Corp., established in 2021 and formerly known as Unicheck Holdings Corp. until April 2021, is a Canadian provider of virtual healthcare and telemedicine solutions. The company's core offering, "Virtual Health Clinics," is a customizable platform engineered to securely connect patients in various settings, from metropolitan areas to isolated regions, with vital medical care. These clinics also empower rapid, real-time diagnostic testing, enable therapeutic interventions, and support continuous health monitoring.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:45 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.16CA$0.00 (0.0%)
Pharmala Biotech Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.52% below the high.
CA$0.08-CA$0.01 (-5.88%)
VentriPoint Diagnostics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 57.89% below the high.
CA$0.02CA$0.00 (0.0%)
PreveCeutical Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
CA$0.06CA$0.00 (0.0%)
Hemostemix Inc.’s quoted price sits in the lower half of its reported 52-week range, 45.45% below the high.
CA$0.03CA$0.00 (0.0%)
Red Light Holland Corp.’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
CA$0.04CA$0.00 (0.0%)
AI/ML Innovations Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.94% below the high.
CA$0.35CA$0.00 (0.0%)
Comprehensive Healthcare Systems, Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.92% below the high.
CA$0.02CA$0.00 (0.0%)
Red White & Bloom Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
